Clinical [qlco]
challenges [hlca]
platelet inhibitor [phsu]
glycoprotein IIb IIIa receptor [aapp, imft, rcpt]
therapy [ftcn]
Bleeding [patf]
Reversal [ftcn]
Thrombocytopenia [fndg]
Retreatment [topp]
Clinical Trials, Randomized [inpr, resa]
Glycoprotein IIb/IIIa [aapp, imft, rcpt]
Integrin Inhibition [moft]
Percutaneous Coronary Intervention [topp]
Adjunctive [topp]
treatment [ftcn]
Syndromes, Acute Coronary [dsyn]
Show [inpr]
Clinical [qlco]
Efficacy [qlco]
Reducing [qlco]
Morbidity [qnco]
mortality rates [qnco]
Cardiovascular disease [dsyn]
Three [qnco]
Agent [chvf]
Currently [tmco]
Available [ftcn]
United States [geoa]
abciximab [aapp, imft, phsu]
ReoPro [aapp, phsu]
eptifibatide [aapp, phsu]
Integrelin [aapp, phsu]
tirofiban [orch, phsu]
Aggrastat [orch, phsu]
Pharmacodynamic Study [resa]
Show [inpr]
abciximab [aapp, imft, phsu]
High [qlco]
Affinity [npop]
Agent [chvf]
low [qlco]
Dissociation [mobd]
eptifibatide [aapp, phsu]
tirofiban [orch, phsu]
High [qlco]
Specificity [qnco]
Agent [chvf]
High [qlco]
Dissociation [mobd]
Concentration [menp]
Dependent [qlco]
Effect [qlco]
This [euka]
Article [inpr]
First [qnco]
Review [inpr]
Relevant [qlco]
PHARMACOKINETIC [resa]
pharmacodynamic [biof]
properties [qlco]
Agent [chvf]
Then [tmco]
Applied [hlca]
Discussion [topp]
Primary [qlco]
Clinical [qlco]
Issue [fndg]
Concern [idcn]
Prevention [topp]
Bleeding [patf]
Algorithms [inpr]
acute [tmco]
Reversal [ftcn]
Recognition [menp]
treatment [ftcn]
Thrombocytopenia [fndg]
Issue [fndg]
Readministration [topp]
